RIL
TXG icon

Rothschild Investment LLC’s 10x Genomics TXG Stock Holding History

Rothschild Investment LLC’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.39K Sell
245
-126
-34% -$3.3K ﹤0.01% 1919
2026
Q1 		$7.88K Buy
371
+75
+25% +$1.5K ﹤0.01% 1815
2025
Q4 		$4.83K Buy
296
+31
+12% +$468 ﹤0.01% 1900
2025
Q3 		$3.1K Hold
265
– – ﹤0.01% 1962
2025
Q2 		$3.07K Buy
265
+255
+2,550% +$2.32K ﹤0.01% 1773
2025
Q1 		$87 Buy
+10
New +$126 ﹤0.01% 2986

Other funds holding TXG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Rothschild Investment LLC's TXG Position: Q2 2026 in Review

Rothschild Investment LLC reduced its 10x Genomics (TXG) stake by 34% in Q2 2026, selling an estimated $3.3K and leaving 245 shares worth $9.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1919.

Rothschild Investment LLC first reported a position in TXG in Q1 2025 and has held it in 6 quarters since. 368 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Rothschild Investment LLC held 245 shares of 10x Genomics worth $9.39K as of Q2 2026.
  • Rothschild Investment LLC sold 126 10x Genomics shares in Q2 2026, an estimated $3.3K.
  • 10x Genomics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1919 holding.
  • Rothschild Investment LLC first reported a position in 10x Genomics in Q1 2025 and has held it in 6 quarters since.
  • 368 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.